- 1. MUC-1 Antigen/SB AS-2
- (UMLS (NCI) C0935745) =Therapeutic or Preventive Procedure
| - 39. Mucoid Stroma Formation
- (UMLS (NCI) C1334812) =Finding ;
|
- 2. MUC-1 KLH Vaccine
- [A peptide vaccine containing human tumor associated epithelial mucin (MUC1) conjugated with keyhole limpet hemocyanin (KLH), with potential antineoplastic activity. MUC1 antigen, a membrane bound glycoprotein expressed by most glandular and ductal epithelial cells, is overexpressed as an aberrant or deglycosylated form in various tumors such as breast, prostate and ovarian cancers. MUC1 antigen is conjugated with KLH, an immunostimulant and a hapten carrier, to enhance immune recognition. Vaccination with MUC1-KLH may result in the production of antibodies as well as elicit a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the MUC1 antigen. ( NCI )] (UMLS (NCI) C0879579) MUC-1-KLH vaccine;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 40. Mucolator
- (UMLS (NCI) C1510763) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
|
- 3. MUC-1 KLH Vaccine/QS21
- (UMLS (NCI) C0879580) =Therapeutic or Preventive Procedure
| - 41. mucolipidosis I
- [ ] (UMLS (CSP) C0268226) =Disease or Syndrome ;
|
- 4. MUC-2-Globo H-KLH Conjugate Vaccine
- [A bivalent vaccine containing a glycosylated epitope of human mucin 2 (MUC2) and the Globo H hexasaccharide 1 (Globo H) antigen with potential antineoplastic activity. MUC2, a secretory or gel forming glycoprotein expressed predominantly in goblet cells of gastrointestinal and respiratory tracts, is overexpressed as an aberrant or deglycosylated form in various tumors such as gastric carcinomas and some hormone-refractory prostate cancers. Originally identified as a globo-series glycosphingolipid with an H-like determinant, Globo H is an epitope commonly found in glycolipids and glycoproteins, including mucins. This vaccine is conjugated with keyhole limpet hemocyanin (KLH), an immunostimulant and a hapten carrier, to enhance immune recognition and stability of the vaccine. Vaccination with this agent may elicit strong antibodies production as well as a cytotoxic T lymphocyte (CTL) response against tumor cells expressing MUC2 or Globo H. ( NCI )] (UMLS (NCI) C0935832) =Organic Chemical; Pharmacologic Substance; Immunologic Factor
| - 42. Mucolyticum
- (UMLS (NCI) C1510764) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
|
- 5. MUC-2-Globo H-KLH Conjugate Vaccine/QS21
- (UMLS (NCI) C1134653) =Therapeutic or Preventive Procedure
| - 43. Mucomyst
- (UMLS (NCI) C0699252) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 6. MUC-2-KLH
- [A peptide vaccine containing human mucin 2 (MUC2) protein conjugated with keyhole limpet hemocyanin (KLH), with potential antineoplastic activity. MUC2, a secretory or gel forming glycoprotein expressed predominantly in goblet cells of gastrointestinal and respiratory tracts, is overexpressed as an aberrant or deglycosylated form in various tumors such as gastric carcinomas and some hormone-refractory prostate cancers. MUC2 protein is conjugated with KLH, an immunostimulant and a hapten carrier, to enhance immune recognition. Vaccination with MUC2-KLH may result in the production of antibodies as well as elicit a cytotoxic T- lymphocyte (CTL) response against tumor cells expressing MUC2. ( NCI )] (UMLS (NCI) C0677979) =Organic Chemical; Pharmacologic Substance; Immunologic Factor
| - 44. mucopeptide
- [ ] (UMLS (CSP) C0599104) =Amino Acid, Peptide, or Protein
|
- 7. MUC-2-KLH Vaccine/QS21
- (UMLS (NCI) C0879436) =Therapeutic or Preventive Procedure
| - 45. mucopolysaccharidosis type VII
- [Mucopolysaccharidosis characterized by excessive dermatan and heparan sulfates in the urine and Hurler-like features. It is caused by a deficiency of beta-glucuronidase. ( MSH )] (UMLS (CSP) C0085132) =Disease or Syndrome ;
=Mucopolysaccharidoses;
|
- 8. MUC1
- [This gene plays a role in cellular signal transduction and is used as a biomarker for breast cancer. ( NCI )] (UMLS (NCI) C1417490) MUC1 Gene;
Mucin 1, Transmembrane Gene =Gene or Genome | - 46. mucoprotein
- [Conjugated proteins in which mucopolysaccharides are combined with proteins. The mucopolysaccharide moiety is the predominant group with the protein making up only a small percentage of the total weight. ( MSH )] (UMLS (CSP) C0026714) =Amino Acid, Peptide, or Protein; Carbohydrate; Biologically Active Substance ;
=glycoprotein;
=intrinsic factor;
|
- 9. Mucambo virus
- [ ] (UMLS (CSP) C0318740) =Virus
| - 47. MUCOPUR CONJUNCTIVIT NEC
- [ ] (UMLS (ICD9CM) C0029668) =Disease or Syndrome
|
- 10. Mucicarmine stain
- [Stain, Mucicarmine ( HL7V3.0 )] (UMLS (HL7) C1293996) =Laboratory Procedure =ObservationMethod;
| - 48. MUCOPURUL CHR BRONCHITIS
- [ ] (UMLS (ICD9CM) C0155873) =Disease or Syndrome
|
- 11. mucin
- [principal component of mucous. ( CSP )] (UMLS (CSP) C0026682) =Amino Acid, Peptide, or Protein; Biologically Active Substance =secretory protein;
| - 49. Mucorales
- [An order of zygomycetous fungi, usually saprophytic, causing damage to food in storage, but which may cause respiratory infection or MUCORMYCOSIS in persons suffering from other debilitating diseases. ( MSH )] (UMLS (CSP) C0026717) =Fungus ;
|
- 12. Mucin-Producing Adenocarcinoma
- [An invasive adenocarcinoma composed of malignant glandular cells which produce mucin. ( NCI )] (UMLS (NCI) C0334368) =Neoplastic Process
| - 50. Mucosa
- (UMLS (HL7) C1561514) =Intellectual Product =Specimen Source Codes;
|
- 13. Mucinol
- (UMLS (NCI) C1448435) =Organic Chemical; Pharmacologic Substance ;
| - 51. mucosa
- [mucus-secreting membrane lining all body cavities or passages that communicate with the exterior. ( CSP )] (UMLS (NCI) C0026724) =Tissue =Epithelial Tissue;
=gastric mucosa;
intestinal mucosa;
mouth mucosa;
|
- 14. Mucinous Adenocarcinoma of Ovary
- [Ovarian mucinous adenocarcinoma is a mucinous neoplasm characterized by cell atypia, increased layering of cells, greater complexity of glands and papillae (budding, bridging, appearance of solid foci) and areas of stromal invasion. —2002 ( NCI )] (UMLS (NCI) C1335167) Mucinous Adenocarcinoma of the Ovary;
Mucinous Carcinoma of Ovary;
Mucinous Carcinoma of the Ovary;
Ovarian Mucinous Adenocarcinoma;
Ovarian Mucinous Carcinoma =Neoplastic Process | - 52. Mucosa of the Lower Lip
- [The lining of the inferior fleshy fold bordering the mouth. It is comprised of the epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae. ( NCI )] (UMLS (NCI) C0226939) =Body Part, Organ, or Organ Component
|
- 15. Mucinous Adenocarcinoma of Stomach
- [A variant of gastric adenocarcinoma with more than half of the tumor containing extracellular mucinous pools. — 2003 ( NCI )] (UMLS (NCI) C1334809) Mucinous Adenocarcinoma of the Stomach;
Mucinous Gastric Adenocarcinoma;
Mucinous Stomach Adenocarcinoma;
=Neoplastic Process ;
| - 53. Mucosa of the Upper Lip
- [The lining of the superior fleshy fold bordering the mouth. It is comprised of the epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae. ( NCI )] (UMLS (NCI) C0226933) =Body Part, Organ, or Organ Component
|
- 16. Mucinous Adenocarcinoma, Endocervical Type
- [A mucinous adenocarcinoma characterized by the presence of malignant glandular cells which resemble the endocervical epithelium. ( NCI )] (UMLS (NCI) C1266079) =Neoplastic Process
| - 54. Mucosal absorption, intraduodenal
- [Mucosal absorption, intraduodenal ( HL7V3.0 )] (UMLS (HL7) C1555401) =Functional Concept =IntraduodenalRoute;
MucosalAbsorptionRoute |
- 17. Mucinous Adenofibroma
- (UMLS (NCI) C0334499) =Neoplastic Process
| - 55. Mucosal absorption, intratracheal
- [Mucosal absorption, intratracheal ( HL7V3.0 )] (UMLS (HL7) C1555402) =Functional Concept =IntratrachealRoute;
MucosalAbsorptionRoute |
- 18. Mucinous Bronchioloalveolar Carcinoma
- [A well differentiated morphologic variant of bronchiolo-alveolar lung carcinoma characterized by tall columnar cells and mucin production. ( NCI )] (UMLS (NCI) C1266035) Mucinous Bronchioloalveolar Lung Carcinoma;
Mucinous Bronchoalveolar Lung Carcinoma =Neoplastic Process | - 56. Mucosal absorption, submucosal
- [Mucosal absorption, submucosal ( HL7V3.0 )] (UMLS (HL7) C1555400) =Functional Concept =SubmucosalRoute;
MucosalAbsorptionRoute |
- 19. Mucinous Cystadenocarcinoma of Ovary
- (UMLS (NCI) C0279665) =Neoplastic Process
| - 57. Mucosal cyst of postmastoidectomy cavity
- [ ] (UMLS (ICD9CM) C0155453) =Disease or Syndrome ;
|
- 20. Mucinous Cystadenofibroma
- (UMLS (NCI) C1377844) =Neoplastic Process
| - 58. Mucosal Immunity
- [immunity induced by the mucosal IgA response for specific resistance toward bacteria, viruses, and parasites infecting the respiratory, gastrointestinal, or genitourinary tracts. ( CSP )] (UMLS (NCI) C0282558) =Organ or Tissue Function ;
=secretory immune system;
|
- 21. Mucinous Cystic Neoplasm of Pancreas with Moderate Dysplasia
- [A low malignant potential cystic epithelial neoplasm arising from the exocrine pancreas. It occurs almost exclusively in women. Small tumors are usually found incidentally. Larger tumors usually produce symptoms related to compression of the adjacent structures. It is characterized by the presence of columnar, mucin-producing epithelial cells which form papillary projections or crypt-like invaginations. There is cellular pseudostratification and mitotic activity present. Complete surgical removal is usually associated with an excellent prognosis. ( NCI )] (UMLS (NCI) C1266077) Mucinous Cystic Neoplasm of the Pancreas with Moderate Dysplasia;
Mucinous Cystic Tumor of Pancreas with Moderate Dysplasia;
Mucinous Cystic Tumor of the Pancreas with Moderate Dysplasia;
Mucinous Cystic Tumor with Moderate Dysplasia;
Pancreatic Borderline Mucinous Cystic Neoplasm;
Pancreatic Low Grade Malignant Mucinous Cystic Neoplasm;
Pancreatic Mucinous Cystic Neoplasm with Moderate Dysplasia;
Pancreatic Mucinous Cystic Tumor with Moderate Dysplasia =Neoplastic Process | - 59. Mucosal Lentiginous Malignant Melanoma
- [An acral lentiginous melanoma affecting mucosal surfaces. ( NCI )] (UMLS (NCI) C1266115) Mucosal Lentiginous Melanoma =Neoplastic Process
|
- 22. Mucinous Degeneration
- (UMLS (NCI) C0333450) =Pathologic Function
| - 60. MucosalAbsorptionRoute
- [Mucosal absorption ( HL7V3.0 )] (UMLS (HL7) C1701746) =Functional Concept =RouteByMethod;
=Mucosal absorption, submucosal;
Mucosal absorption, intraduodenal;
Mucosal absorption, intratracheal |
- 23. Mucinous Lesion
- (UMLS (NCI) C1334810) =Finding ;
| - 61. mucositis
- [A complication of some cancer therapies in which the lining of the digestive system becomes inflamed. Often seen as sores in the mouth. ( NCI )] (UMLS (NCI) C0333355) =Pathologic Function
|
- 24. Mucinous Neoplasm
- (UMLS (NCI) C1334811) Mucinous Tumor =Neoplastic Process ;
| - 62. Mucositis (ulcerative) due to antineoplastic therapy
- [ ] (UMLS (ICD9CM) C1719526) MUCOSITS D/T ANTINEO RX;
=Disease or Syndrome |
- 25. Mucinous Neoplasm of Ovary
- [Ovarian mucinous neoplasms are less common than the serous neoplasms and are bilateral in only 10% to 20% of the cases.As with their serous counterpart, they can be divided into benign (mucinous cystadenoma), borderline and malignant (mucinous adenocarcinoma and mucinous cystadenocarcinoma). Grossly, they tend to grow larger than the serous types and are partially or completely cystic, often multiloculated. A mucoid material is present in the lumen. —2002 ( NCI )] (UMLS (NCI) C1335168) Mucinous Neoplasm of the Ovary;
Mucinous Tumor of Ovary;
Mucinous Tumor of the Ovary;
Ovarian Mucinous Neoplasm;
Ovarian Mucinous Tumor =Neoplastic Process | - 63. Mucositis (ulcerative) due to other drugs
- [ ] (UMLS (ICD9CM) C1719527) MUCOSITIS D/T DRUGS NEC;
=Disease or Syndrome |
- 26. Muckleshoot Indian Tribe of the Muckleshoot Reserv
- (UMLS (HL7) C1554385) =Population Group =NativeEntityContiguous;
| - 64. Mucositis (ulcerative) of cervix, vagina, and vulva
- [ ] (UMLS (ICD9CM) C1719543) MUCOSITIS CERV,VAG,VULVA =Disease or Syndrome
|
- 27. Mucocedyl
- (UMLS (NCI) C1510762) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 65. Mucosolvin
- (UMLS (NCI) C0699253) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 28. Mucocele of salivary gland
- [A form of retention cyst of the floor of the mouth, usually due to obstruction of the ducts of the submaxillary or sublingual glands, presenting a slowly enlarging painless deep burrowing mucocele of one side of the mouth. It is also called sublingual cyst and sublingual ptyalocele. ( MSH )] (UMLS (ICD9CM) C0026686) =Disease or Syndrome; Anatomical Abnormality =cyst;
Mouth Diseases | - 66. mucous
- [A thick, slippery fluid produced by the membranes that line certain organs of the body, including the nose, mouth, throat, and vagina. ( NCI )] (UMLS (CSP) C0026727) =Body Substance =body fluid;
=bronchial mucous;
|
- 29. Mucocutaneous Candidiasis
- (UMLS (NCI) C0006848) =Disease or Syndrome
| - 67. mucous colon
- [ ] (UMLS (CSP) C0598736) =Disease or Syndrome ;
|
- 30. Mucoepidermoid Breast Carcinoma
- [A carcinoma of the breast characterized by pools of mucin and islands of malignant squamous cells. Mucoepidermoid carcinomas of the breast are extremely rare. —2003 ( NCI )] (UMLS (NCI) C1334813) Mucoepidermoid Carcinoma of Breast;
Mucoepidermoid Carcinoma of the Breast;
=Neoplastic Process ;
| - 68. Mucous Connective Tissue
- [Loose connective tissue, the intercellular matrix of which consists predominantly of mucoid ground substance. Examples: Mucoid tissue of umbilical cord, mucoid tissue of vitreous body, mucoid tissue of nucleus pulposus. ( UWDA )] (UMLS (NCI) C0225345) =Tissue
|
- 31. Mucoepidermoid Carcinoma of Oral Cavity
- (UMLS (NCI) C0280309) =Neoplastic Process
| - 69. Mucous Membrane
- (UMLS (HL7) C1549524) =Functional Concept =drug administration route;
|
- 32. Mucoepidermoid Carcinoma of Parotid
- (UMLS (NCI) C1335363) Mucoepidermoid Carcinoma of Parotid Gland;
Mucoepidermoid Carcinoma of the Parotid;
Mucoepidermoid Carcinoma of the Parotid Gland;
Parotid Gland Mucoepidermoid Carcinoma;
Parotid Mucoepidermoid Carcinoma =Neoplastic Process ;
| - 70. Mucous Membrane Hemangioma
- [A hemangioma arising from the mucous membranes. ( NCI )] (UMLS (NCI) C0240392) =Finding
|
- 33. Mucoepidermoid Carcinoma of Salivary Gland
- (UMLS (NCI) C1335903) Mucoepidermoid Carcinoma of the Salivary Gland;
Salivary Gland Mucoepidermoid Carcinoma;
=Neoplastic Process ;
| - 71. Mucous Membrane Leukoplakia
- (UMLS (NCI) C0240396) =Finding
|
- 34. Mucoepidermoid Carcinoma of Skin
- (UMLS (NCI) C0346019) =Neoplastic Process
| - 72. MUCOUS POLYP OF CERVIX
- (UMLS (ICD9CM) C0026725) =Neoplastic Process
|
- 35. Mucoepidermoid Carcinoma of Submandibular Gland
- (UMLS (NCI) C1336524) Mucoepidermoid Carcinoma of the Submandibular Gland;
Submandibular Gland Mucoepidermoid Carcinoma;
=Neoplastic Process ;
| - 73. Mucous Salivary Gland
- (UMLS (NCI) C0227440) =Body Part, Organ, or Organ Component
|
- 36. Mucoepidermoid Carcinoma of the Thymus
- [A rare primary thymic carcinoma, characterized by the presence of squamous cells, intermediate type cells, and mucus-producing cells. Published information on clinical course is limited to single-case reports. — 2005 ( NCI )] (UMLS (NCI) C1334814) Mucoepidermoid Carcinoma of Thymus;
Thymic Mucoepidermoid Carcinoma;
Thymus Mucoepidermoid Carcinoma =Neoplastic Process ;
| - 74. MucousMembraneRoute
- [Mucous membrane ( HL7V3.0 )] (UMLS (HL7) C1700803) =Functional Concept ;
=RouteBySite;
=Topical application, mucous membrane;
|
- 37. mucoid
- [ ] (UMLS (CSP) C0205295) =Qualitative Concept
| - 75. Mucret
- (UMLS (NCI) C1510765) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
|
- 38. mucoid exopolysaccharide Pseudomonas aeruginosa
- [ ] (UMLS (CSP) C0599235) =Carbohydrate; Immunologic Factor
| - 76. Mucus
- (UMLS (HL7) C1546714) =Intellectual Product =Specimen Source Codes;
|
home
